Merck reports positive results from the first two phase 3 CORALreef trials of enlicitide decanoate to treat adults with hyperlipidemia: Rahway, New Jersey Tuesday, June 10, 2025, ...

CII Telangana to hold ‘Pillars of Protection’ conference on pharma & chemical industries safety on June 25 at Hyderabad: Our Bureau, Bengaluru Tuesday, June 10, 2025, 09:00 Hr ...

Biocon Foundation with NCBS & BeST Cluster launches BioWISE Programme to empower women in STEM: Our Bureau, Bengaluru Monday, ...

Peethaambaran Kunnathoor, Chennai Tuesday, June 10, 2025, 08:00 Hrs [IST] ...

Experts support Centre’s ban on medical representatives from Central govt hospitals for sales promotion: Shardul Nautiyal, Mumbai Tuesday, June 10, 2025, 08:00 Hrs [IST] Followi ...

DHN unveils landmark Annual Digital Health Trends & Outlook 2025 Report at its Delhi Forum; AI emerges as top priority: Our ...

The leading 30 pharmaceutical companies, with revenues above Rs 2,500 crore, have registered robust net profit growth of 31 per cent during the financial year 2024-25 on account of new product ...

Hospitals work on data protection for responsible patient care: Dr Sameer Bhati: Nandita Vijayasimha, Bengaluru Tuesday, June 10, 2025, 08:00 Hrs [IST] Healthcare systems are incr ...

CDSCO, DAHD to form JWG to monitor use of antimicrobials in animals: Gireesh Babu, New Delhi Tuesday, June 10, 2025, 08:00 Hrs [IST] In an effort to control the use of antimicrobi ...

Mediar Therapeutics doses first patient in phase 2 WISPer trial of MTX-463 for idiopathic pulmonary fibrosis: Boston Monday, June 9, 2025, 15:00 Hrs [IST] Mediar Therapeutics, Inc ...

MEDSIR announces positive results from TUXEDO-3 trial of patritumab deruxtecan in patients with active brain metastases and leptomeningeal disease: Chicago Monday, June 9, 2025, 1 ...

US FDA clears YolTech’s IND application for YOLT-101, an in vivo base editing therapy to treat heterozygous familial hypercholesterolemia: Shanghai, China Monday, June 9, 2025, ...